In breast cancer GLI1 is upregulated due to the loss of lysine methyltransferases (KMT) SETD7 which can put repressive marks on histones within GLI1 promoter and loss of these marks results in GLI1 overexpression [170]. This evidence concerns the gene GLI1 and breast cancer.